MX2018011052A - Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica. - Google Patents
Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica.Info
- Publication number
- MX2018011052A MX2018011052A MX2018011052A MX2018011052A MX2018011052A MX 2018011052 A MX2018011052 A MX 2018011052A MX 2018011052 A MX2018011052 A MX 2018011052A MX 2018011052 A MX2018011052 A MX 2018011052A MX 2018011052 A MX2018011052 A MX 2018011052A
- Authority
- MX
- Mexico
- Prior art keywords
- synthesis
- inocarboxyamide
- tryptam
- incorporation
- protected
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30024—Cell structures in vitro; Tissue sections in vitro
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30036—Dental; Teeth
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Theoretical Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Quality & Reliability (AREA)
- Radiology & Medical Imaging (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
Se proporcionan, Triptamina-2' deoxiuridina (TrpdU), TrpdU fosforamiditas y Triptamina modificada para la síntesis de oligonucleótidos así como métodos mejorados de su síntesis y oligonucleótidos que comprenden al menos un nucleótido TrpdU modificado.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662308132P | 2016-03-14 | 2016-03-14 | |
PCT/US2017/022007 WO2017160672A1 (en) | 2016-03-14 | 2017-03-13 | Compounds and methods for the synthesis of 5-(n-protected-tryptaminocarboxyamide)-2'-deoxyuridine phosphoramidate for incorporation into a nucleic sequence |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018011052A true MX2018011052A (es) | 2019-01-24 |
Family
ID=58410476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018011052A MX2018011052A (es) | 2016-03-14 | 2017-03-13 | Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica. |
Country Status (18)
Country | Link |
---|---|
US (2) | US10634679B2 (es) |
EP (1) | EP3430022B1 (es) |
JP (1) | JP6853265B2 (es) |
KR (1) | KR102269009B1 (es) |
CN (1) | CN108779140B (es) |
AR (1) | AR107867A1 (es) |
AU (1) | AU2017233994B2 (es) |
BR (1) | BR112018017316B1 (es) |
CA (1) | CA3017853A1 (es) |
DK (1) | DK3430022T3 (es) |
ES (1) | ES2784946T3 (es) |
HK (1) | HK1257431A1 (es) |
IL (1) | IL261250A (es) |
MX (1) | MX2018011052A (es) |
RU (1) | RU2750989C2 (es) |
SG (2) | SG11201807079UA (es) |
TW (1) | TWI733772B (es) |
WO (1) | WO2017160672A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10049447B2 (en) * | 2013-11-06 | 2018-08-14 | H. Lee Moffitt Cancer Center and Research Insititute, Inc. | Pathology case review, analysis and prediction |
WO2024121253A1 (en) * | 2022-12-06 | 2024-06-13 | Mihkal Gmbh | Novel n,n-dimethyltryptamine (dmt) derivatives and uses thereof |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4899014B2 (ja) * | 1995-06-02 | 2012-03-21 | イーシー・テクノロジー・エルエルシー | 求核試薬および一酸化炭素を用いるパラジウム触媒ヌクレオシド修飾方法 |
US5945527A (en) * | 1996-05-30 | 1999-08-31 | Nexstar Pharmaceuticals, Inc. | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
IL138825A (en) * | 2000-10-03 | 2006-06-11 | Neurim Pharma 1991 | Pharmaceutical preparations containing tryptamine derivatives and similar compounds, and such new compounds |
KR20070061893A (ko) | 2004-09-22 | 2007-06-14 | 트리패스 이미징, 인코포레이티드 | 유방암 예후를 평가하기 위한 방법 및 조성물 |
US8249326B2 (en) | 2005-11-25 | 2012-08-21 | British Columbia Cancer Agency Branch | Apparatus and methods for automated assessment of tissue pathology |
CA2604317C (en) * | 2007-08-06 | 2017-02-28 | Historx, Inc. | Methods and system for validating sample images for quantitative immunoassays |
US9684001B2 (en) * | 2008-02-07 | 2017-06-20 | Ranju Ralhan | Biomarkers for head-and-neck cancers and precancers |
CN102165489B (zh) * | 2008-09-16 | 2015-11-25 | 赫斯托克斯公司 | 生物标志物表达的可再现量化 |
JP5544833B2 (ja) | 2009-11-17 | 2014-07-09 | 富士通株式会社 | インドール基用保護基 |
CA3066785A1 (en) * | 2010-04-12 | 2011-10-20 | Somalogic, Inc. | 5-position modified pyrimidines and their use |
AU2013202528B2 (en) * | 2010-04-12 | 2015-07-30 | Somalogic Operating Co., Inc. | 5-position modified pyrimidines and their use |
AU2011248632B2 (en) | 2010-04-27 | 2015-07-02 | Prelude Corporation | Cancer biomarkers and methods of use thereof |
US20140235487A1 (en) | 2010-11-12 | 2014-08-21 | William Marsh Rice University | Oral cancer risk scoring |
EP3553527A1 (en) | 2011-03-17 | 2019-10-16 | Cernostics, Inc. | Systems and compositions for diagnosing barrett's esophagus and methods of using the same |
TWI541249B (zh) * | 2011-04-12 | 2016-07-11 | 身體邏輯公司 | 5-位置經修飾之嘧啶類及彼等之用途 |
EP2639238A1 (en) | 2012-03-15 | 2013-09-18 | Universität Bern | Tricyclic nucleosides and oligomeric compounds prepared therefrom |
EP2772882A1 (en) * | 2013-03-01 | 2014-09-03 | Universite D'angers | Automatic measurement of lesions on medical images |
WO2014144657A2 (en) | 2013-03-15 | 2014-09-18 | Metamark Genetics, Inc. | Compositions and methods for cancer prognosis |
LT2984108T (lt) * | 2013-04-09 | 2017-11-10 | Lykera Biomed, S.A. | Anti-s100a7 antikūnai, skirti vėžio gydymui ir diagnozei |
US10983126B2 (en) | 2013-05-31 | 2021-04-20 | The Brigham And Women's Hospital | System and method for analyzing tissue for the presence of cancer using bio-marker profiles |
SG11201602063UA (en) | 2013-09-24 | 2016-04-28 | Somalogic Inc | Multiaptamer target detection |
JP6574240B2 (ja) | 2014-03-30 | 2019-09-11 | セフィエド | 修飾シトシンポリヌクレオチドオリゴマーおよび方法 |
EP2933639A1 (en) * | 2014-04-16 | 2015-10-21 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | S100p and Hyaluronic acid as biomarkers for metastatic breast cancer |
CN106459133B (zh) | 2014-06-10 | 2019-12-06 | 安捷伦科技有限公司 | 用于“z核苷酸”的保护基团及其方法 |
EP3155592B1 (en) * | 2014-06-10 | 2019-09-11 | Leland Stanford Junior University | Predicting breast cancer recurrence directly from image features computed from digitized immunohistopathology tissue slides |
US9298968B1 (en) * | 2014-09-12 | 2016-03-29 | Flagship Biosciences, Inc. | Digital image analysis of inflammatory cells and mediators of inflammation |
WO2016087592A1 (en) * | 2014-12-03 | 2016-06-09 | Ventana Medical Systems, Inc. | Systems and methods for early-stage cancer prognosis |
WO2017012555A1 (zh) * | 2015-07-20 | 2017-01-26 | 徐敏 | 光子结构和化学计量学病理系统 |
-
2017
- 2017-03-13 JP JP2018547892A patent/JP6853265B2/ja active Active
- 2017-03-13 AU AU2017233994A patent/AU2017233994B2/en active Active
- 2017-03-13 CN CN201780012492.8A patent/CN108779140B/zh active Active
- 2017-03-13 CA CA3017853A patent/CA3017853A1/en active Pending
- 2017-03-13 TW TW106108101A patent/TWI733772B/zh active
- 2017-03-13 WO PCT/US2017/022007 patent/WO2017160672A1/en active Application Filing
- 2017-03-13 SG SG11201807079UA patent/SG11201807079UA/en unknown
- 2017-03-13 EP EP17713541.5A patent/EP3430022B1/en active Active
- 2017-03-13 BR BR112018017316-9A patent/BR112018017316B1/pt active IP Right Grant
- 2017-03-13 AR ARP170100622A patent/AR107867A1/es unknown
- 2017-03-13 RU RU2018135738A patent/RU2750989C2/ru active
- 2017-03-13 ES ES17713541T patent/ES2784946T3/es active Active
- 2017-03-13 US US16/078,859 patent/US10634679B2/en active Active
- 2017-03-13 MX MX2018011052A patent/MX2018011052A/es unknown
- 2017-03-13 DK DK17713541.5T patent/DK3430022T3/da active
- 2017-03-13 KR KR1020187026253A patent/KR102269009B1/ko active IP Right Grant
- 2017-03-13 SG SG10201911357VA patent/SG10201911357VA/en unknown
- 2017-03-14 US US16/083,663 patent/US11585816B2/en active Active
-
2018
- 2018-08-20 IL IL261250A patent/IL261250A/en active IP Right Grant
- 2018-12-27 HK HK18116643.7A patent/HK1257431A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20180116312A (ko) | 2018-10-24 |
RU2750989C2 (ru) | 2021-07-07 |
IL261250A (en) | 2018-10-31 |
TWI733772B (zh) | 2021-07-21 |
JP6853265B2 (ja) | 2021-03-31 |
US20190031702A1 (en) | 2019-01-31 |
AU2017233994B2 (en) | 2021-02-18 |
SG11201807079UA (en) | 2018-09-27 |
CN108779140B (zh) | 2022-04-12 |
HK1257431A1 (zh) | 2019-10-18 |
SG10201911357VA (en) | 2020-01-30 |
RU2018135738A (ru) | 2020-04-15 |
US10634679B2 (en) | 2020-04-28 |
EP3430022A1 (en) | 2019-01-23 |
EP3430022B1 (en) | 2020-03-11 |
US11585816B2 (en) | 2023-02-21 |
AR107867A1 (es) | 2018-06-13 |
TW201734030A (zh) | 2017-10-01 |
JP2019508438A (ja) | 2019-03-28 |
US20190072559A1 (en) | 2019-03-07 |
WO2017160672A1 (en) | 2017-09-21 |
RU2018135738A3 (es) | 2020-07-22 |
CA3017853A1 (en) | 2017-09-21 |
BR112018017316A2 (pt) | 2019-01-02 |
CN108779140A (zh) | 2018-11-09 |
DK3430022T3 (da) | 2020-05-18 |
KR102269009B1 (ko) | 2021-06-28 |
BR112018017316B1 (pt) | 2022-08-02 |
AU2017233994A1 (en) | 2018-08-30 |
ES2784946T3 (es) | 2020-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020001158A (es) | Composiciones nucleotidicas modificadas con citidina-5-carboxamida y metodos relacionados con las mismas. | |
WO2016106400A3 (en) | Rna interference agents for gst-pi gene modulation | |
MX2017008183A (es) | Nucleosidos sustituidos, nucleotidos y analogos de estos. | |
PH12015501423A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
SG10201804835VA (en) | Substituted nucleosides, nucleotides and analogs thereof | |
PH12015502799A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
PH12014502094B1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
PH12015502273A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
NZ607996A (en) | Substituted nucleotide analogs | |
MX2016017381A (es) | Nucleosidos sustituidos, nucleotidos y analogos de los mismos. | |
NZ630890A (en) | Microrna compounds and methods for modulating mir-122 | |
MX2021001590A (es) | Oligonucleótidos modificados dirigidos a snp. | |
MX2018002998A (es) | Derivado de acido nucleico que tiene actividad inmunoestimuladora. | |
MX2019005101A (es) | Microarns modificados con 5-halouracilo y su uso en el tratamiento del cancer. | |
MX2021004932A (es) | Composiciones de oligonucleotidos y metodos para realizarlas. | |
MX2018011052A (es) | Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica. | |
CA3156667A1 (en) | OLIGONUCLEOTIDES INCLUDING NUCLEOSIDE ANALOGS | |
EP3418289A4 (en) | ARTIFICIAL NUCLEOSIDE AND ARTIFICIAL NUCLEOTIDE AND ARTIFICIAL OLIGONUCLEOTIDE | |
MY186779A (en) | Nucleic acid derivative having immunostimulatory activity | |
WO2017074036A3 (ko) | 암 환자의 유전체 염기서열 변이 정보와 생존 정보를 이용한 맞춤형 약물 선택 방법 및 시스템 | |
EP3350195A4 (en) | METHOD FOR SYNTHESIS AND PURIFICATION OF A NUCLEOSIDE AND / OR A NUCLEOTIDE, MODIFIED NUCLEOSIDE AND / OR NUCLEOTIDE, DNA MOLECULAR AND OLIGONUCLEOTIDE LIBRARY WITH THIS MODIFIED NUCLEOSIDE AND / OR NUCLEOTIDE AND USE OF THE OLIGONUCLEOTIDE LIBRARY | |
EA202190483A1 (ru) | Модифицированные олигонуклеотиды, нацеливающиеся на snp | |
FR2906532B1 (fr) | Nouvel oligonucleotide marque | |
MY194299A (en) | Oligonucleotides and a method for detecting and/or quantifying human rhinovirus | |
TH182360A (es) |